We aim to define how Alzheimer’s disease emerges and progresses across genetic and sporadic forms by integrating spatial and single-nucleus transcriptomics in human brain tissue, leveraging Down syndrome–associated Alzheimer’s disease as a genetically driven model to bridge mechanisms between inherited risk and late-onset sporadic disease, mapping gray- and white-matter–specific cell-type–resolved molecular programs in their native spatial context to uncover layer-…
The Tenner laboratory is contributing to the emerging understanding of the role of the complement system in directing an appropriate immune response, with a specific focus on neurodegenerative conditions like Alzheimer’s disease (AD).
Our mission is to advance next-generation vaccines using mRNA-lipid nanoparticle technologies to counter pathogens of high public health concern and pandemic potential . We are committed to accelerating the design, evaluation, and translation of multivalent, scalable vaccine platforms that address emerging infectious diseases, neglected threats, and biodefense-relevant agents.
Our lab investigates how to protect the cortex from ischemic stroke . We induce stroke through permanent occlusion of the middle cerebral artery (MCA) and employ various methods to image blood flow and neuronal activity.
We use machine learning, AI methods, clinical informatics, and population data to understand Alzheimer’s disease, dementia, and migraine with the goal of transforming how neurological conditions are diagnosed and treated.
Therefore, Our research aims to uncover the spatial and temporal dynamics of immune responses in physiological settings using a combination of advanced multiphoton imaging of fluorescently tagged cells, fate-mapped reporters, and functional genetics in animal models of autoimmune encephalomyelitis, orthotopic tumors, and vaccine responses.
The Thompson laboratory has been actively engaged in investigating the fundamental molecular and cellular events that underlie how the mutant Huntington’s disease gene causes degeneration of specific brain cell populations to induce motor and cognitive decline and premature death of patients with the ultimate goal to develop new therapeutic approaches.
Specifically, we are interested in further studying how Tat, a small protein produced in an HIV infected cell, prevents the IP from generating peptides for MHC I display and development of a small molecule to prevent the IP‑HIV Tat interaction.
Our lab focuses on integrative neuroscience research on learning and memory mechanisms with translational applications to education, technology, and clinical disorders.
The Neurology Traumatic Brain Injury & Concussion (NTBIC) Program is a rapidly growing multi specialty collaborative clinical -research program encompassing an inpatient and clinic service. The novel program recognizes the diverse recoveries and experiences of TBI patients.